CIPLA: News

17 May 2024

Stock Market

Sensex gains over 250 points, Nifty ends above 22,460 mark

On Friday, the benchmark Sensex and Nifty indices showed an upward trend.

10 May 2024

Stock Market

Sensex gains 260 points, Nifty settles above 22,050 mark

On Friday, the benchmark Sensex and Nifty indices saw some gains after trading in the red for several sessions.

31 Mar 2024

Indian Government

PLI schemes attract over Rs. 1L crore investments until December

Indian government data reveals that production-linked incentive (PLI) schemes across 14 sectors have attracted investments exceeding Rs. 1.06 lakh crore up to December 2023.

27 Oct 2023

Stock Market

Cipla clocks 45% YoY profit growth in Q2 FY24

Cipla declared its Q2 FY24 financial results today, showcasing a net profit of Rs. 1,155.37 crore, a whopping 44.9% growth compared to Rs. 797.41 crore in Q2 FY23.

20 Oct 2023

Business

Torrent secures funding to buy 33% stake in Cipla

Torrent Pharmaceuticals Ltd. is reportedly eyeing a 33% stake in Mumbai-based drugmaker Cipla, having secured at least $5 billion in funding from a group of overseas banks.

19 Sep 2023

Business

Torrent Pharma seeks $1 billion loan for Cipla bid

India's Torrent Pharmaceutical is in preliminary discussions with Apollo Global Management to secure a loan of up to $1 billion, aiming to fund a planned bid for its larger rival, Cipla, according to Reuters.

13 Jun 2023

Stock Market

Sensex gains nearly 420 points, Nifty settles above 18,700 mark

On Tuesday, the benchmark Sensex and Nifty indices saw gains. While the Sensex rose 0.66% to settle at 63,143.16 points, the Nifty jumped 0.61% to 18,716.15 points.

25 Aug 2022

Ethereum

Sensex closes at 58,774 points, Nifty settles at 17,522

The stock market on Thursday ended on a sluggish note as the Sensex fell by 0.53% to settle at 58,774.72 points, while the Nifty declined by 0.47% to end at 17,522.45 points.

29 Jun 2021

Vaccine

Cipla gets DCGI nod to import Moderna COVID-19 vaccine

The Drugs Controller General of India (DCGI) has reportedly allowed the pharmaceutical firm Cipla to import the COVID-19 vaccine developed by US-based biotechnology company Moderna Inc.

24 May 2021

COVID-19

Roche's Antibody Cocktail launched in India, priced at Rs. 59,750/dose

Drug majors Roche India and Cipla on Monday announced the launch of Roche's Antibody Cocktail in India priced at Rs. 59,750 per dose for treatment of mild to moderate COVID-19 in patients who are at high risk.

Coronavirus: Zydus Cadila launches cheapest version of Remdesivir in India

In a major development, Zydus Cadila has launched the cheapest generic version of Remdesivir, the antiviral drug being used to treat COVID-19, in India.

25 Jun 2020

Tamil Nadu

Coronavirus: 5 states to receive first batch of Hetero's COVIFOR

Five states across India will be the first to receive Hetero Healthcare's COVID-19 drug, COVIFOR, the first generic brand of the experimental drug remdesivir.

These drugs are in use for COVID-19 treatment in India

India has opened up, but the pandemic is not slowing down.

05 Mar 2020

India

India's five most influential and successful women in finance

The world of finance used to be seen as an industry only for men for the longest time. However, that has changed in the last few years.

02 Dec 2019

Africa

Cipla's new strawberry-flavored medicine can save kids from AIDS

In a bid to save thousands of children from HIV AIDS, Indian pharmaceutical company Cipla has introduced a revolutionary new drug called Quadrimune.

16 Jul 2019

India

India's five most influential and successful women in finance

The world of finance used to be seen as an industry only for men for the longest time. However, that has changed in the last few years.

14 Aug 2016

India

Cipla boss calls Subhanu Saxena quits; cites family reasons

Cipla chief executive Subhanu Saxena confirmed that he would no longer be serving as the head of the company.